Profile data is unavailable for this security.
About the company
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
- Revenue in CAD (TTM)36.35k
- Net income in CAD-2.65m
- Incorporated2006
- Employees--
- LocationSirona Biochem Corpc/o WeWork, 595 Burrard St.VANCOUVER V7X 1L4CanadaCAN
- Phone+1 (604) 641-4466
- Fax+1 (604) 608-5471
- Websitehttps://www.sironabiochem.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avricore Health Inc | 3.49m | -701.22k | 15.47m | -- | -- | 7.69 | -- | 4.44 | -0.007 | -0.007 | 0.035 | 0.0202 | 1.36 | -- | 5.96 | -- | -27.46 | -85.75 | -35.30 | -142.65 | 34.53 | 31.65 | -20.12 | -116.09 | 1.42 | -28.44 | 0.0195 | -- | 97.08 | 196.15 | 14.30 | -- | 80.26 | -- |
| Antibe Therapeutics Inc | 0.00 | -18.24m | 15.63m | 11.00 | -- | 0.599 | -- | -- | -0.3466 | -0.3525 | 0.00 | 0.4925 | 0.00 | -- | -- | 0.00 | -28.04 | -41.95 | -29.31 | -46.17 | -- | -- | -- | -349.76 | -- | -- | 0.00 | -- | -- | -- | 23.60 | -- | -29.21 | -- |
| Sirona Biochem Corp | 36.35k | -2.65m | 17.95m | -- | -- | -- | -- | 493.68 | -0.0105 | -0.0105 | 0.0001 | -0.011 | 0.0492 | -- | 7.70 | -- | -358.70 | -173.09 | -- | -383.49 | -- | -- | -7,297.85 | -1,405.28 | -- | -9.04 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Kane Biotech Inc | 148.98k | -4.56m | 18.45m | -- | -- | -- | -- | 123.85 | -0.0359 | -0.0396 | 0.0012 | -0.0801 | 0.0264 | 0.0779 | 0.9169 | -- | -80.74 | -77.89 | -- | -- | 73.48 | 43.27 | -3,062.39 | -241.85 | 0.3188 | -2.78 | 10.99 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
| Cytophage Technologies Ltd | 0.00 | -4.64m | 19.34m | -- | -- | 8.15 | -- | -- | -0.5489 | -0.5489 | 0.00 | 0.0442 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -165.33 | 0.8283 | -- | -- | -- | -25.88 | -- | -- | -- |
| Ceapro Inc | 9.63m | -4.71m | 19.57m | 12.00 | -- | 0.7027 | -- | 2.03 | -0.0602 | -0.0602 | 0.1231 | 0.3558 | 0.2785 | 1.25 | 6.45 | -- | -13.62 | 2.46 | -14.42 | 2.59 | 41.07 | 52.27 | -48.89 | 5.13 | 5.49 | -39.49 | 0.0747 | 0.00 | -48.87 | -3.64 | -207.09 | -- | -3.60 | -- |
